BR9913108A - Delta3-piperidinas tricìclicas como produtos farmacêuticos - Google Patents
Delta3-piperidinas tricìclicas como produtos farmacêuticosInfo
- Publication number
- BR9913108A BR9913108A BR9913108-0A BR9913108A BR9913108A BR 9913108 A BR9913108 A BR 9913108A BR 9913108 A BR9913108 A BR 9913108A BR 9913108 A BR9913108 A BR 9913108A
- Authority
- BR
- Brazil
- Prior art keywords
- delta3
- pharmaceutical products
- compounds
- piperidines
- tricyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Patente de Invenção: <B>"DELTA3-PIPERIDINAS TRICìCLICAS COMO PRODUTOS FARMACêUTICOS"<D>. A presente invenção refere-se aos compostos de fórmula (I), às formas N-óxido, aos sais de adição farmaceuticamente aceitáveis e às formas estereoquimicamente isoméricas dos compostos, onde Alk é C~ 1-6~alcanodiíla; n é 1 ou 2; X é -O-, -S-, -S(=O)- ou -S(=O)~ 2~-, cada R¹ é independentemente hidrogênio, halogênio, C~ 1-6~alquila, nitro, hidróxi, ou C~ 1-4~alquilóxi; D é um indol, um benzisoxazol, um benzisotiazol, uma 2H-benzopiranona, uma fenoxifenila, uma benzamida, uma benzofenona ou uma benzopirimidinona que apresenta atividade central antagonista a adreno-receptores <244>~ 2~. A presente invenção refere-se adicionalmente à sua preparação, uso farmacêutico e composições.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203371 | 1998-10-06 | ||
| PCT/EP1999/007420 WO2000020423A1 (en) | 1998-10-06 | 1999-10-01 | Tricyclic δ3-piperidines as pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9913108A true BR9913108A (pt) | 2001-05-08 |
Family
ID=8234192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9913108-0A BR9913108A (pt) | 1998-10-06 | 1999-10-01 | Delta3-piperidinas tricìclicas como produtos farmacêuticos |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6352999B1 (pt) |
| EP (1) | EP1119570B1 (pt) |
| JP (1) | JP4590102B2 (pt) |
| KR (1) | KR20010071844A (pt) |
| CN (1) | CN1131868C (pt) |
| AR (1) | AR023679A1 (pt) |
| AT (1) | ATE269337T1 (pt) |
| AU (1) | AU759199B2 (pt) |
| BG (1) | BG64871B1 (pt) |
| BR (1) | BR9913108A (pt) |
| CA (1) | CA2346082C (pt) |
| CZ (1) | CZ20011105A3 (pt) |
| DE (1) | DE69918148T2 (pt) |
| EE (1) | EE04680B1 (pt) |
| ES (1) | ES2222735T3 (pt) |
| HK (1) | HK1038009A1 (pt) |
| HU (1) | HUP0103749A3 (pt) |
| ID (1) | ID28451A (pt) |
| IL (2) | IL142444A0 (pt) |
| NO (1) | NO20011402L (pt) |
| NZ (1) | NZ510116A (pt) |
| PL (1) | PL347179A1 (pt) |
| RU (1) | RU2226194C2 (pt) |
| SK (1) | SK285386B6 (pt) |
| TR (1) | TR200100953T2 (pt) |
| TW (1) | TWI244485B (pt) |
| UA (1) | UA70961C2 (pt) |
| WO (1) | WO2000020423A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
| CA2451606A1 (en) | 2001-07-05 | 2003-01-16 | Pharmacia & Upjohn Company | (hetero) aryl substituted benzofurans as 5-ht ligands |
| CA2480266C (en) * | 2002-04-03 | 2011-07-12 | Orion Corporation | Use of an alpha2-adrenoreceptor antagonist for cns-related diseases |
| CA2562406C (en) | 2004-04-12 | 2013-03-19 | Taisho Pharmaceutical Co., Ltd. | Cyclic amine compound |
| EP1856126A2 (en) | 2005-02-17 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| ES2897946T3 (es) | 2013-07-25 | 2022-03-03 | Dong A St Co Ltd | Método para preparar un derivado de benzamida, intermedio novedoso utilizado en la preparación de la benzamida y método para preparar un intermedio novedoso |
| CN103755715B (zh) * | 2013-12-26 | 2015-12-09 | 武汉理工大学 | 苯并呋喃并[2,3-c]吡啶化合物及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3522959A1 (de) | 1985-06-27 | 1987-01-08 | Merck Patent Gmbh | Indolderivate |
| US4673680A (en) * | 1985-09-18 | 1987-06-16 | Pendleton Robert G | α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
| US4985422A (en) * | 1988-04-27 | 1991-01-15 | Glaxo Group Limited | Lactam derivatives |
| US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| PT942911E (pt) * | 1996-12-06 | 2002-04-29 | Abbott Lab | Compostos alfa 1 adrenergicos de benzopiranopirrolo e benzopiranopiridina |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
-
1999
- 1999-10-01 CZ CZ20011105A patent/CZ20011105A3/cs unknown
- 1999-10-01 CA CA2346082A patent/CA2346082C/en not_active Expired - Fee Related
- 1999-10-01 ES ES99950628T patent/ES2222735T3/es not_active Expired - Lifetime
- 1999-10-01 RU RU2001111811/04A patent/RU2226194C2/ru not_active IP Right Cessation
- 1999-10-01 ID IDW20010779A patent/ID28451A/id unknown
- 1999-10-01 EE EEP200100210A patent/EE04680B1/xx not_active IP Right Cessation
- 1999-10-01 UA UA2001032000A patent/UA70961C2/uk unknown
- 1999-10-01 EP EP99950628A patent/EP1119570B1/en not_active Expired - Lifetime
- 1999-10-01 AT AT99950628T patent/ATE269337T1/de not_active IP Right Cessation
- 1999-10-01 TW TW088116897A patent/TWI244485B/zh not_active IP Right Cessation
- 1999-10-01 US US09/806,587 patent/US6352999B1/en not_active Expired - Lifetime
- 1999-10-01 IL IL14244499A patent/IL142444A0/xx active IP Right Grant
- 1999-10-01 TR TR2001/00953T patent/TR200100953T2/xx unknown
- 1999-10-01 NZ NZ510116A patent/NZ510116A/xx unknown
- 1999-10-01 KR KR1020017000443A patent/KR20010071844A/ko active Search and Examination
- 1999-10-01 CN CN998116688A patent/CN1131868C/zh not_active Expired - Fee Related
- 1999-10-01 HU HU0103749A patent/HUP0103749A3/hu unknown
- 1999-10-01 AU AU63342/99A patent/AU759199B2/en not_active Ceased
- 1999-10-01 WO PCT/EP1999/007420 patent/WO2000020423A1/en not_active Application Discontinuation
- 1999-10-01 PL PL99347179A patent/PL347179A1/xx not_active Application Discontinuation
- 1999-10-01 BR BR9913108-0A patent/BR9913108A/pt not_active Application Discontinuation
- 1999-10-01 JP JP2000574535A patent/JP4590102B2/ja not_active Expired - Fee Related
- 1999-10-01 SK SK433-2001A patent/SK285386B6/sk unknown
- 1999-10-01 DE DE69918148T patent/DE69918148T2/de not_active Expired - Lifetime
- 1999-10-05 AR ARP990105041A patent/AR023679A1/es active IP Right Grant
-
2001
- 2001-03-12 BG BG105334A patent/BG64871B1/bg unknown
- 2001-03-20 NO NO20011402A patent/NO20011402L/no not_active Application Discontinuation
- 2001-04-04 IL IL142444A patent/IL142444A/en not_active IP Right Cessation
- 2001-12-10 HK HK01108630A patent/HK1038009A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307406A (pt) | Indóis substituìdos como agonistas alfa-1 | |
| BR9915403A (pt) | Antagonistas receptores iii de 4-aroil-piperidin-ccr-3 | |
| BR9915735A (pt) | Antagonistas receptores de ccr-3 de piperidina | |
| BR0009702A (pt) | Compostos ou seus sais, uso de compostos ou sais, e, formulações farmacêuticas | |
| BR0114754A (pt) | Compostos não-imidazóis | |
| NO20024339D0 (no) | 1,2,3,4-Tetrahydroisokinolin-derivater | |
| BR0109235A (pt) | Derivados do ácido carboxìlico como antagonistas ip | |
| AP9901531A0 (en) | Method and novel compounds for use therein. | |
| BR0112359A (pt) | Derivados de aminoácidos aza-bicìclicos ligados por ponte como antagonistas de integrina alfa4 | |
| BRPI9909191B8 (pt) | derivados de pirimidina inibidores do hiv, seu uso e composição farmacêutica que os compreende | |
| BR9803179A (pt) | Antagonistas receptores de ccr-3. | |
| ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
| BR9913542A (pt) | Derivados de dihidrobenzodioxina carboxamida e dihidrobenzodioxina cetona como antagonistas do receptor 5-ht4 | |
| BRPI0514976A (pt) | composto esteroidal 15beta-substituìdo, composição farmacêutica, e, uso de um composto | |
| BR0102083A (pt) | Uso de derivados de alfa-cetoenamina como ingredientes | |
| BR0013653A (pt) | Compostos moduladores de receptores de andrógeno e progesterona bicìclicos e processos de produção e de uso | |
| BR0012697A (pt) | Inibidores da diferenciação de th2 | |
| CA2360313A1 (en) | Glucocorticoid receptor modulators | |
| BR9913108A (pt) | Delta3-piperidinas tricìclicas como produtos farmacêuticos | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| BRPI0417268A (pt) | benzimidazóis que contêm morfolinila, como inibidores da replicação de vìrus sinciciais respiratórios | |
| HUP0100865A2 (hu) | Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BRPI0414558A (pt) | composição farmacêutica compreendendo um antagonista do receptor p2x7 e uma droga antiinflamatória não esteróide | |
| BR9811769A (pt) | Tetraidro gama-carbolinas | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADO DE INT.CL: C07D 495/04; C07D 491/048; A61K 31/4355; A61K 31/4353; A61P 25/00 Ipc: C07D 495/04 (2008.01), C07D 491/048 (2008.01), A61 |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |